🔎 Trials Near Me

Gara Jalqabaatti › Darmaatiitisiis › California

Qorannoo klinikaalii Darmaatiitisiis California keessatti

Qorannoo 6 Darmaatiitisiis f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Fountain Valley
  • Novartis Investigative Site, Los Angeles
  • Novartis Investigative Site, Sacramento
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06947993

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

  • Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
  • University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm, San Diego
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 11 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06807268

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

  • Alliance Clinical West Hills (Focus Clinical Research), West Hills
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07527923

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  • Northridge Clinical Trials, Northridge
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Marvel Research, LLC, Huntington Beach
  • Metropolis Dermatology, Los Angeles
  • Dermatology Research Associates, Los Angeles
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 1, Lancaster
  • Inmagene Site 23, Los Angeles
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07037901

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.